American International Group’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-119,145
| Closed | -$3.53M | – | 3036 |
|
|
2023
Q4 | $3.53M | Sell |
119,145
-480
| -0.4% | -$9.56K | 0.01% | 842 |
|
|
2023
Q3 | $1.9M | Buy |
119,625
+2,803
| +2% | +$46.6K | 0.01% | 971 |
|
|
2023
Q2 | $2.2M | Buy |
116,822
+13,198
| +13% | +$156K | 0.01% | 944 |
|
|
2023
Q1 | $398K | Buy |
103,624
+2,062
| +2% | +$8.79K | ﹤0.01% | 1730 |
|
|
2022
Q4 | $504K | Sell |
101,562
-370
| -0.4% | -$2.01K | ﹤0.01% | 1586 |
|
|
2022
Q3 | $487K | Buy |
101,932
+1,441
| +1% | +$7.6K | ﹤0.01% | 1591 |
|
|
2022
Q2 | $452K | Sell |
100,491
-6,215
| -6% | -$27K | ﹤0.01% | 1671 |
|
|
2022
Q1 | $508K | Buy |
106,706
+1,590
| +2% | +$8.8K | ﹤0.01% | 1713 |
|
|
2021
Q4 | $780K | Sell |
105,116
-3,145
| -3% | -$19.5K | ﹤0.01% | 1561 |
|
|
2021
Q3 | $614K | Sell |
108,261
-1,224
| -1% | -$7.07K | ﹤0.01% | 1714 |
|
|
2021
Q2 | $722 | Sell |
109,485
-2,310
| -2% | -$16.1K | ﹤0.01% | 1706 |
|
|
2021
Q1 | $906 | Buy |
111,795
+4,408
| +4% | +$36K | ﹤0.01% | 1518 |
|
|
2020
Q4 | $693 | Buy |
107,387
+4,648
| +5% | +$27.1K | ﹤0.01% | 1586 |
|
|
2020
Q3 | $370K | Sell |
102,739
-2,336
| -2% | -$9.43K | ﹤0.01% | 1756 |
|
|
2020
Q2 | $483K | Buy |
105,075
+5,049
| +5% | +$21.5K | ﹤0.01% | 1611 |
|
|
2020
Q1 | $341K | Buy |
100,026
+9,210
| +10% | +$40.3K | ﹤0.01% | 1620 |
|
|
2019
Q4 | $464K | Sell |
90,816
-765
| -0.8% | -$2.6K | ﹤0.01% | 1729 |
|
|
2019
Q3 | $222K | Sell |
91,581
-637
| -0.7% | -$1.69K | ﹤0.01% | 2107 |
|
|
2019
Q2 | $200K | Buy |
92,218
+676
| +0.7% | +$1.6K | ﹤0.01% | 2234 |
|
|
2019
Q1 | $248K | Sell |
91,542
-2,967
| -3% | -$12.9K | ﹤0.01% | 2102 |
|
|
2018
Q4 | $454K | Sell |
94,509
-726
| -0.8% | -$4.41K | ﹤0.01% | 1725 |
|
|
2018
Q3 | $902K | Buy |
95,235
+11,747
| +14% | +$113K | ﹤0.01% | 1506 |
|
|
2018
Q2 | $812K | Buy |
83,488
+19,640
| +31% | +$207K | ﹤0.01% | 1523 |
|
|
2018
Q1 | $672K | Sell |
63,848
-3,432
| -5% | -$33.9K | ﹤0.01% | 1507 |
|
|
2017
Q4 | $431K | Buy |
67,280
+10,849
| +19% | +$66.9K | ﹤0.01% | 1876 |
|
|
2017
Q3 | $432K | Buy |
56,431
+4,219
| +8% | +$28K | ﹤0.01% | 1843 |
|
|
2017
Q2 | $371K | Buy |
52,212
+349
| +0.7% | +$1.6K | ﹤0.01% | 1901 |
|
|
2017
Q1 | $201K | Buy |
51,863
+3,418
| +7% | +$9.97K | ﹤0.01% | 2181 |
|
|
2016
Q4 | $99K | Sell |
48,445
-125
| -0.3% | -$251 | ﹤0.01% | 2612 |
|
|
2016
Q3 | $130K | Buy |
48,570
+74
| +0.2% | +$215 | ﹤0.01% | 2454 |
|
|
2016
Q2 | $149K | Sell |
48,496
-3,922
| -7% | -$24.6K | ﹤0.01% | 2341 |
|
|
2016
Q1 | $447K | Sell |
52,418
-3,131
| -6% | -$26.5K | ﹤0.01% | 2087 |
|
|
2015
Q4 | $754K | Buy |
55,549
+459
| +0.8% | +$5.65K | ﹤0.01% | 1687 |
|
|
2015
Q3 | $529K | Sell |
55,090
-2,440
| -4% | -$35.7K | ﹤0.01% | 1975 |
|
|
2015
Q2 | $827K | Sell |
57,530
-3,953
| -6% | -$43.4K | ﹤0.01% | 1737 |
|
|
2015
Q1 | $550K | Sell |
61,483
-150
| -0.2% | -$1.09K | ﹤0.01% | 2082 |
|
|
2014
Q4 | $376K | Sell |
61,633
-2,435
| -4% | -$22.3K | ﹤0.01% | 2384 |
|
|
2014
Q3 | $678K | Buy |
64,068
+1,508
| +2% | +$17.1K | ﹤0.01% | 1869 |
|
|
2014
Q2 | $741K | Sell |
62,560
-1,346
| -2% | -$16.9K | ﹤0.01% | 1831 |
|
|
2014
Q1 | $954K | Buy |
63,906
+1,380
| +2% | +$21.8K | ﹤0.01% | 1565 |
|
|
2013
Q4 | $917K | Sell |
62,526
-2,172
| -3% | -$33.4K | ﹤0.01% | 1535 |
|
|
2013
Q3 | $1.1M | Buy |
64,698
+2,734
| +4% | +$48.1K | 0.01% | 1346 |
|
|
2013
Q2 | $1.03M | Buy |
+61,964
| New | +$1M | 0.01% | 1367 |
|
Other funds holding IMGN
American International Group's IMGN Position: Q1 2024 in Review
American International Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 119,145 shares — an estimated $3.53M sold.
American International Group first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $3.53M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- American International Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- American International Group sold 119,145 Immunogen Inc shares in Q1 2024, an estimated $3.53M.
- American International Group first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
- American International Group's Immunogen Inc position peaked at $3.53M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on American International Group's 13F filing for Q1 2024, filed 13 May 2024.